MetaCap

Churchill Capital XI (CCXI) vs Drugs Made In America Acquisition II (DMII)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.

Summary

Drugs Made In America Acquisition II is the larger company by market cap ($649.1 million vs $614.9 million), about 1.1 times the size.

Summary generated from market data by MetaCap's automated system. Methodology

Head-to-head

CCXI versus DMII key metrics
MetricCCXIDMII
Share price$11.04$10.19
Market cap$614.93M$649.10M
1-day change-1.78%0.00%
P/E ratio (TTM)—33.97
EPS (TTM)—$0.30
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
52-week high$19.69$10.33
52-week low$10.07$9.86
Distance from 52-week high-43.93%-1.36%
Average volume2.59M54.52K
Shares outstanding41.90M63.70M
SectorFinanceFinance
IndustryBlank ChecksBlank Checks

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

About Churchill Capital XI

CCXI stock →

Churchill Capital Corp XI does not have significant operations. It intends to effect a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses.

Finance · Blank Checks

About Drugs Made In America Acquisition II

DMII stock →

Drugs Made In America Acquisition II Corp. does not have significant operations.

Finance · Blank Checks

CCXI vs DMII FAQ

Which is bigger, Churchill Capital XI or Drugs Made In America Acquisition II?

Drugs Made In America Acquisition II (DMII) is larger, with a market capitalization of $649.10M compared with $614.93M for Churchill Capital XI (CCXI).

Are Churchill Capital XI and Drugs Made In America Acquisition II in the same industry?

Yes. Both are classified in the Blank Checks industry within the Finance sector.

More comparisons